The Latest in Hematology Times

FDA approves first anti-CD19 drug

December 4, 2014

ASH adds practices to Choosing Wisely list

December 4, 2014

Study shows long-term survival improvements in blood cancers

December 3, 2014

Drug gets orphan designation for MM & CLL/SLL

December 3, 2014

FDA grants drug orphan designation for AML

December 3, 2014

NICE offers conditional support for eculizumab

December 3, 2014

Targeting enzyme can eliminate CSCs in AML

December 2, 2014

NICE expands use of ESAs in cancer patients

December 2, 2014

Drug dubbed ‘breakthrough’ for AL amyloidosis

December 2, 2014

HHS and NIH aim to make more trial results public

December 2, 2014

Related Issues

Mutations indicate predisposition to blood cancers

December 1, 2014

Health Canada expands indication for apixaban

November 30, 2014

Studies reveal secrets of malaria transmission

November 29, 2014

Related Issues

Injectable hydrogel promotes coagulation

November 28, 2014

Thrombosis

FDA influence on design of pivotal drug studies

November 27, 2014